SUMMARY In order to study the clinical, serological, and morphological evolution of chronic hepatitis B virus infection in childhood, a prospective study has been carried out. A total of 90 children with a chronic infection were followed up for a mean (SD) 
household contact. Two children had a previous transfusion, and in 11 children the cause of the infection was unknown. Serology for the presence of markers for hepatitis B virus, anti-HIV, antihepatitis delta (anti-HD), and liver function tests were performed every four months using standard methods (Abbott commercial assays and SMAC Technicon). HBV-DNA was tested by dot-blot hybridisation, using a HBV-DNA probe isolated from the pBH20-HBV plasmid. The specific activity of the 32P-HBV-DNA after nicktranslation was 7 x 107-3 x 108 cpm4lg DNA. This technique detected less than 0-5 pg of HBV-DNA.
At the beginning of the study a liver biopsy was performed under general anaesthesia in 78 of the 90 children using a Tru-Cut needle. A second liver biopsy was performed during a mean follow up of three years (range from eight months to seven years) in 27 children. The presence of liver HDAg among anti-HD positive patients was detected by immunoperoxidase staining using a conjugated anti-HD antibody (anti-HD titre: 1/1000). Liver HBsAg and hepatitis B core antigen (HBcAg) were also tested by immunoperoxidase technique (Dakopatts a/s).
Results
In relation to the 'e' system, 77 children were HBeAg positive and 13 had anti-HBe. A total of 71 of the HBeAg positive children had circulating HBV-DNA. HBeAg positive patients had a significantly higher mean (SD) initial alanine aminotransferase activity than those with anti-HBe (232 (289) compared with 37 (14) IU/1). During follow up 24 became negative for HBeAg and HBV-DNA and 21 developed anti-HBe. The time from the beginning of the study until the seroconversion to anti-HBe varied from six months to five (2.3 (1.4)) years. The annual seroconversion rate was 14%. None of the anti-HBe children had HBV-DNA, although two were anti-HD positive.
At the end of the study all the children were clinically asymptomatic. With respect to the physical signs the frequency of hepatomegaly increased in the children who remained with HBeAg (basal 13 (24%) compared with final 31 (58%)), while a decrease was observed in children who seroconverted to anti-HBe (basal 10 (47%) compared with final three (14%)). No changes were observed in the antiHBe children (basal five (38%) compared with final two (15%)).
Among the 21 children who seroconverted to antiHBe, an increase of at least three times the basal alanine aminotransferase value (18 (12) times the normal value) before seroconversion was observed in 18 cases (85%). The time between the alanine aminotransferase peak and the appearance of antiHBe was 13 (5.6) months (range: 6-28 months).
These alanine aminotransferase peaks were similar to those found in acute hepatitis, although the children did not suffer any symptom or clinical complication. All the children who seroconverted to anti-HBe had normal alanine aminotransferase by 4-3 (5.8) months (range: 0-17 months) and remained so during the follow up (two years). Eight children who were anti-HBe positive initially had normal alanine aminotransferase activities. Two children returned to normal in 12 months but three remained abnormal in follow up periods of 38 to 72 months. Two of the latter had anti-HD in serum and HDAg in the liver biopsy specimen.
A basal liver biopsy was performed on 68 of the 71 children with viral replication markers (HBeAg, HBV-DNA). Although most of the children (n=54) had a chronic active hepatitis, 11 had a chronic persistent hepatitis, two had liver active cirrhosis, and one had minimal changes. After the beginning of the study, a second liver biopsy was obtained in 24 children. Of the 17 who remained positive to HBeAg, the histological picture was the same in nine cases. The other eight children showed a worsening of the histological lesion (table 3). All 17 The basal histology of the 10 anti-HBe positive patients was two with chronic active hepatitis, six with chronic persistent hepatitis, one with inactive cirrhosis, and one with minimal changes. The liver histology from the second biopsy specimen obtained in the three anti-HBe children who remained with an abnormal alanine aminotransferase activity, resulted in the same histological findings in two cases (HDAg positive). In the HDAg negative pat'aent, an amelioration of the histological lesion was observed.
Discussion
In our experience children with hepatitis B virus replication markers suffered a more active liver disease biochemically and histologically than those without replication. These results are in accordance with previous reports.7 8 Although at the end of the study all the children were asymptomatic, in those who seroconverted to anti-HBe a decrease in the frequency of hepatomegaly was observed, with an important histological improvement. In contrast, children who remained HBeAg positive had an increase in the frequency of hepatomegaly and a progression of the histological lesion (in some cases to liver active cirrhosis). This result is lower than those reported by other authors,4 5 All the children from our study who seroconverted remained HBsAg positive; this is in accordance with previous studies.6 8 Thus the risk of the development of hepatoma probably persists in these children.11 Further studies are required to indicate if HBV-DNA remains in an integrated form after seroconversion.
The children with persistent viral replication had a diffuse pattern of HBcAg in the liver. In contrast, those children who seroconverted to anti-HBe showed a focal pattern. These results agree with those of Bortolotti et al, 12 and so testing for HBcAg in the liver could be useful as a prognosis indicator.
During seroconversion, an increase in alanine aminotransferase activity similar to that in acute hepatitis was observed in most of the children. In our experience, however, only 50% of the adults who seroconverted had a previous alanine aminotransferase increase. 13 Although we are unsure as to the reason for this difference between adults and children from the same population, a possible explanation is the difference in their immune systems. In support of this theory, we observed an important regression of liver disease in adults during seroconversion while none was detected in the children.14 This variation could be due to the fact that liver cirrhosis is less common in children, or also that they regenerate the liver cells more quickly than adults.
With the exception of two patients with delta superinfection, all the children with anti-HBe and abnormal alanine aminotransferase activity at the beginning of the study had normal alanine aminotransferase at the end of the follow up period.
Therefore, the anti-HBe status in children correlated with a normal alanine aminotransferase activity and good prognosis in the absence of the delta virus. During the follow up reactivation of viral replication in the anti-HBe children did not take place as all the children remained HBV-DNA negative in contrast with that reported in adults. '5 A similar lack of HBV-DNA among anti-HBe children has been reported. 2 5 This suggests that clearance of all HBV-DNA replicative forms in hepatocytes occurred in these children. In adults, however, HBV-DNA supercoiled could remain in hepatocytes due to the lack of elimination and consequently reactivation takes place in about 40% of anti-HBe cases (unpublished data).
This study confirms the high frequency of advanced liver disease in association with chronic hepatitis B virus infection and a persistently raised serum transaminase activity for a period of more than six months. Such patients should be considered for treatment with antiviral agents both to limit progression of liver disease and to reduce the risks of HBV-DNA integration and the subsequent development of hepatoma. 16 17 In such a case, if the treatment is efficient, the prognosis of the disease will be more favourable.'8 JB was supported by a grant from the Fondo de Investigaciones Sanitarias de la Seguridad Social, Insalud.
